Mohammad Azab

(Dr. Mohammad Azab)

Currently holds positions in Astex Pharmaceuticals Inc and Xenon Pharmaceuticals Inc

Positions
Position Company Period
Chief Medical Officer Astex Pharmaceuticals Inc July 21, 2009 -
Independent Director Xenon Pharmaceuticals Inc Oct. 1, 2003 -
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Total value Details
2022-05-25 2022-05-24
US DURECT Corp (DRRX)
B Purchase
5,000 +9.1%
0.39
1,950 USD
5,000 +9.1% 0.39 1,950 USD
2022-05-25 2022-05-24
US DURECT Corp (DRRX)
B Purchase
10,000 +22.2%
0.39
3,889 USD
10,000 +22.2% 0.39 3,889 USD
2022-05-25 2022-05-24
US DURECT Corp (DRRX)
B Purchase
5,000 +12.5%
0.38
1,895 USD
5,000 +12.5% 0.38 1,895 USD
2022-05-25 2022-05-24
US DURECT Corp (DRRX)
B Purchase
5,000 +14.3%
0.39
1,942 USD
5,000 +14.3% 0.39 1,942 USD
2022-05-25 2022-05-24
US DURECT Corp (DRRX)
B Purchase
5,000 +16.7%
0.39
1,963 USD
5,000 +16.7% 0.39 1,963 USD
2022-05-18 2022-05-17
US DURECT Corp (DRRX)
B Purchase
1,800 +6.4%
0.42
758 USD
1,800 +6.4% 0.42 758 USD
2022-05-18 2022-05-17
US DURECT Corp (DRRX)
B Purchase
8,900 +46.1%
0.42
3,749 USD
8,900 +46.1% 0.42 3,749 USD
2022-05-18 2022-05-17
US DURECT Corp (DRRX)
B Purchase
9,300 +93.0%
0.42
3,899 USD
9,300 +93.0% 0.42 3,899 USD
2022-05-18 2022-05-16
US DURECT Corp (DRRX)
B Purchase
10,000 +inf%
0.38
3,767 USD
10,000 +inf% 0.38 3,767 USD
2019-09-17 2019-09-13
S Sale
23 -0.0%
9.31
214 USD
23 -0.0% 9.31 214 USD